Business Description
Biosergen AB
ISIN : SE0016013460
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.81 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -30.1 | |||||
3-Year EPS without NRI Growth Rate | -26.9 | |||||
3-Year FCF Growth Rate | -54 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.82 | |||||
9-Day RSI | 55.16 | |||||
14-Day RSI | 56.21 | |||||
6-1 Month Momentum % | 74.9 | |||||
12-1 Month Momentum % | -0.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.16 | |||||
Quick Ratio | 5.16 | |||||
Cash Ratio | 3.27 | |||||
Days Payable | 2742.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.9 | |||||
Shareholder Yield % | -26.41 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -239.2 | |||||
ROA % | -164.78 | |||||
ROIC % | -283.65 | |||||
3-Year ROIIC % | 306.59 | |||||
ROC (Joel Greenblatt) % | -329.55 | |||||
ROCE % | -238.18 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 6.39 | |||||
Price-to-Tangible-Book | 6.39 | |||||
EV-to-EBIT | -3.28 | |||||
EV-to-Forward-EBIT | -5.43 | |||||
EV-to-EBITDA | -3.28 | |||||
EV-to-FCF | -3.29 | |||||
Price-to-Net-Current-Asset-Value | 6.34 | |||||
Price-to-Net-Cash | 11.61 | |||||
Earnings Yield (Greenblatt) % | -30.49 | |||||
FCF Yield % | -26.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biosergen AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.018 | ||
Beta | 2.18 | ||
Volatility % | 180.4 | ||
14-Day RSI | 56.21 | ||
14-Day ATR (€) | 0.004571 | ||
20-Day SMA (€) | 0.05284 | ||
12-1 Month Momentum % | -0.84 | ||
52-Week Range (€) | 0.0194 - 0.079165 | ||
Shares Outstanding (Mil) | 142.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biosergen AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biosergen AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biosergen AB Frequently Asked Questions
What is Biosergen AB(FRA:8N1)'s stock price today?
When is next earnings date of Biosergen AB(FRA:8N1)?
Does Biosergen AB(FRA:8N1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |